Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K160859
    Manufacturer
    Date Cleared
    2016-07-13

    (106 days)

    Product Code
    Regulation Number
    886.5916
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    OPTIMUM GP OK Daily Wear Contact Lens (roflufocon D & E)

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The OPTIMUM GP OK contact lenses are indicated for daily wear in an orthokeratology fitting program for the temporary reduction of myopia of up to 5.00 diopters in non-diseased eyes. To maintain the orthokeratology effect of myopia reduction, lens wear must be continued on a prescribed wearing schedule.

    Eyecare practitioners may prescribe the lenses for frequent/planned replacement wear, with cleaning, disinfection and scheduled replacement. When prescribed for frequent wear, the lens may be cleaned and disinfected using a chemical (not heat) lens care system.

    Device Description

    The OPTIMUM GP OK Daily Wear Contact Lens (roflufocon D & E) may be prescribed in a daily wear orthokeratology fitting program for the temporary reduction of myopia of up to 5.00 diopters in non-diseased eyes.

    The OPTIMUM GP OK Daily Wear Contact Lens (roflufocon D & E) is a rigid gas permeable methacrylate copolymer of Methyl methacrylate, 1,1,1,3,3 - Hexafluoroisopropy] Methacrylate, Methacryloxypropyl Tris(trimethylsiloxy) silane, 1,3-bis(methacryloxypropyl)-1,1,3,3-tetrakis(trimethyl siloxy)disiloxane, 2-Hydroxyethyl Methacrylate, and Methacrylic acid cross-linked with Ethylene Glycol Dimethacrylate.

    The OPTIMUM GP OK Daily Wear Contact Lens (roflufocon D & E) may be packaged and shipped "dry" or "wet" in a polypropylene contact lens case. The primary container for shipping the OPTIMUM GP OK lenses is the PolyVial /PolyPack Contact Lens Case. When shipped "wet", the OPTIMUM GP OK lenses may be packaged and shipped in the Optimum Cleaning, Disinfecting and Storage (CDS) GP solution. The active ingredients in Optimum GP Cleaning Disinfecting and Storage solution are Lauryl salt of imidazoline, octylphenoxypolyethoxyethanol, and preserved with benzyl alcohol 0.3% and disodium edetate 0.5%.

    The OPTIMUM GP OK Daily Wear Contact Lens (roflufocon D & E) incorporates a visibility tint to make the lens more visible for handling. The tinted lenses contain one or more of the following color additives: D&C Green No.6. C.I. Solvent yellow No. 18. and FD&C Red No. 17.

    In the OPTIMUM GP OK Daily Wear Contact Lens (roflufocon D & E) with UV Blocker, a Benzophenone UV blocking monomer is used to block UV radiation. The UV Blocker is 2,2 -Dihydroxy-4,4'dimethoxybenzophenone. The UV blocking for OPTIMUM GP averages > 98% in the UVB range of 280nm – 315nm and 95% in the UVA range of 316 – 380nm.

    AI/ML Overview

    The provided text is a 510(k) summary for the OPTIMUM GP OK (Orthokeratology) Daily Wear Contact Lens. It does not describe a study that uses acceptance criteria in the manner typically associated with AI/ML device performance evaluations. The document focuses on demonstrating substantial equivalence to predicate devices for regulatory clearance, rather than presenting a detailed clinical or technical study with specific performance metrics and acceptance thresholds for a novel device function.

    Therefore, many of the requested fields cannot be directly extracted or are not applicable from this type of regulatory document.

    However, I can extract information related to product specifications and a comparison to predicate devices, which serve a similar purpose in demonstrating that the new device is "as good as" existing, cleared devices.

    Here's an attempt to answer the questions based on the provided text, while noting where information is not available:

    1. Table of Acceptance Criteria and Reported Device Performance

    This document does not present "acceptance criteria" in the context of a statistical study with performance metrics (e.g., sensitivity, specificity, accuracy) for a new algorithm or diagnostic test. Instead, it demonstrates substantial equivalence by comparing the physical and chemical properties and indications for use of the proposed device to legally marketed predicate devices. The "performance" here is that its characteristics are similar enough to existing devices to not raise new questions of safety and effectiveness.

    Here's a table comparing key characteristics of the subject device with its predicates, as presented in the document:

    CharacteristicOPTIMUM GP OK (Subject Device)Predicate: OPTIMUM GP (K033594) (roflufocon D & E)Predicate: CONTEX OK (K973697) (siflufocon A)Predicate: BOSTON XO2 (K071266) (hexafocon B)
    Indication for UseDaily wear in orthokeratology for temporary reduction of myopia up to 5.00 dioptersManagement of irregular corneal conditions (not orthokeratology)Daily wear in orthokeratology for temporary reduction of myopia up to 3.00 dioptersDaily wear in orthokeratology for temporary reduction of myopia up to 5.00 diopters
    Device ClassificationClass II rigid gas permeable contact lensClass II rigid gas permeable contact lensClass II rigid gas permeable contact lensClass II rigid gas permeable contact lens
    Product CodeMUWHQDMUWMUW
    Production MethodLathe-cutLathe-cutLathe-cutLathe-cut
    USAN (Material)roflufocon D, & Eroflufocon A, B, C, D, & Esiflufocon Ahexafocon B
    FDA Group #Group # 3 Fluoro Silicone AcrylateGroup # 3 Fluoro Silicone AcrylateGroup # 3 Fluoro Silicone AcrylateGroup # 3 Fluoro Silicone Acrylate
    Oxygen Permeability (Dk)D: 100, E: 125D: 100, E: 12581141
    Water Content
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1